MAR 25, 2016 7:22 AM PDT

Can Oxytocin Levels Predict Postpartum Depression?

WRITTEN BY: Xuan Pham
Oxytocin and postpartum depression

In a surprising report that goes against expectations, researchers at Northwestern University found that higher levels of the hormone oxytocin is correlated with increased risks for postpartum depression. But does this really make sense?
 
The results surprised even the researchers who conducted the study, as they expected postpartum depression to be associated with lower oxytocin levels.
 
Oxytocin is a hormone released by the pituitary gland in the brain. It’s often referred to as the “cuddle hormone” or the “love hormone” as the chemical is released during times of social bonding. In women, the hormone is especially important in labor and delivery. During nursing, suckling of the breast by a baby stimulates the flood of oxytocin to the woman’s body, which then causes her body to produce more milk for the baby. These processes, regulated by oxytocin, increase mother-child bonding and should promote wellness postpartum.
 
In a cohort of 66 healthy pregnant women, researchers identified 13 in the group that had a history of major depressive disorder and 53 that did not. They measured the oxytocin levels in these women at the third trimester and signs of depressive symptoms at 6 weeks postpartum. The researchers noted no differences between the two groups in terms of demographic factors or birth outcomes.
 
The research team reported that higher oxytocin levels predicted greater postpartum depression symptoms in women with a past history of depression only. In other words, the results say that women who experienced prior depression and have high oxytocin levels at the third trimester are more likely to experience postpartum depression.
 
But there’s much room for skepticism in these results, especially given the knowledge of how oxytocin acts to promote mother-child bonding and stress management. Dubiously, the strange correlation only holds up for women with a past history of depression. To address this obvious question, Suena Massey, first study author, said, “There's emerging research that a past history of depression can change the oxytocin receptor in such a way that it becomes less efficient. Perhaps, when women are starting to experience early signs of depression, their bodies release more oxytocin to combat it."
 
Perhaps this could be a new adaptive mechanism in postpartum depression. But with such a small sample size, these speculations are far from convincing.
 
To be more conclusive, the researchers would need to significantly increase the sample size, and they would also need to make more stringent comparisons. For example, are there differences in oxytocin levels in women with a past history of depression that did not experience postpartum depression? And what about women who develop postpartum depression but had no prior history?
 
The study authors acknowledge these limitations, but propose that oxytocin could be a predictor in postpartum depression. “It's not ready to become a new blood test yet," Massey acknowledged. "But it tells us that we are on the track to identifying biomarkers to help predict postpartum depression." 
 

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 01, 2020
Cardiology
Avoiding Caries in Children
APR 01, 2020
Avoiding Caries in Children
Thankfully, children are free of many of the chronic diseases that plague older populations. That said, one of the most ...
APR 07, 2020
Clinical & Molecular DX
Computers Predict Diabetes with 94.9 Percent Accuracy
APR 07, 2020
Computers Predict Diabetes with 94.9 Percent Accuracy
"Currently we do not have sufficient methods for predicting which generally healthy individuals will develop diabet ...
MAY 04, 2020
Immunology
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
JUN 07, 2020
Genetics & Genomics
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
JUN 07, 2020
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
When children have a rare genetic disease and do not have access to whole-genome sequencing and the analysis it requires ...
JUL 10, 2020
Cancer
Researching New RNA Biomarkers for Liver Cancer
JUL 10, 2020
Researching New RNA Biomarkers for Liver Cancer
The most important part of cancer treatment is the first step, diagnosis. Many cancers can lie dormant for years, reachi ...
JUL 23, 2020
Clinical & Molecular DX
Prostate Cancer: To Treat or Not to Treat
JUL 23, 2020
Prostate Cancer: To Treat or Not to Treat
After a prostate cancer diagnosis, urologists do not always initiate immediate clinical intervention. In those with Low- ...
Loading Comments...